| Literature DB >> 28724653 |
Lixin Jia1,2,3,4, Wenmei Zhang1,2,3, Youcai Ma1,2,3,4, Boya Chen1,2,3, Yan Liu1,2,3, Chunmei Piao1,2,3, Yuan Wang1,2,3, Min Yang1,2,3, Tingting Liu1,2,3, Junmeng Zhang1,2,3, Taotao Li1,2,3, Shaoping Nie5, Jie Du6,2,3.
Abstract
BACKGROUND: Cell senescence is involved in the process of organ damage and repair; however, the underlying molecular mechanism needs to be further explored. METHODS ANDEntities:
Keywords: angiogenesis; fibroblasts; myocardial infarction; senescence; vascular endothelial growth factor
Mesh:
Substances:
Year: 2017 PMID: 28724653 PMCID: PMC5586323 DOI: 10.1161/JAHA.117.006349
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Senescence is involved in post–myocardial infarction (MI) cardiac remodeling in mouse heart. A, Real‐time polymerase chain reaction (PCR) analysis of ataxia telangiectasia mutated (ATM), p53, and p21 mRNA levels at days 0, 3, and 7 after MI. B, Real‐time PCR analysis of ATM, p53, and p21 mRNA levels in sham mouse and different regions (remote area, border area, and infarct area) at day 7 post MI. n=4 in each group. *P<0.05 vs the day 0 or sham group. Western blot analysis and bar graph of (C) p21 expression in wild‐type mouse hearts at indicated times after sham or MI surgery, and (D) p21 expression in different regions of wild‐type mouse hearts 7 days after sham or MI surgery. E, Representative images and (F) statistical analysis of senescence‐associated β‐galactosidase (SA‐β‐gal) staining in mouse hearts at day 7 after sham or MI surgery. n=4 in each group. *P<0.05 vs the sham group, **P<0.01 vs the sham group. G, Representative images of costaining of SA‐β‐gal and α‐smooth muscle actin (α‐SMA)/α‐actinin staining in heart section at day 7 after MI surgery. Bar=50 μm.
Figure 2Senescence‐associated gene expression in infarcted mouse heart. Immunostaining and bar graph of senescent‐related proteins ataxia telangiectasia mutated (ATM), p16, p21, and p53 expression in infarcted mouse heart at the indicated time (infarct area). n=5 in each group. *P<0.05, **P<0.01 vs the day 0 group. Bar=50 μm. MI indicates myocardial infarction; HF, high‐power field.
Figure 3Ataxia telangiectasia mutated (ATM) haplodeficiency aggravated cardiac dysfunction post myocardial infarction (MI). A, Survival rates were analyzed in ATM +/+ and ATM +/− mice after sham or MI surgery. Echocardiography was performed to show (B) ejection fraction and (C) fraction shortening change in ATM +/+ and ATM +/− mice after sham or MI surgery. *P<0.05 vs the ATM +/− MI group.
Body and Organ Weights and Echocardiographic Data 28 Days Post MI
| Sham | MI | |||
|---|---|---|---|---|
| ATM+/+ (n=4) | ATM+/− (n=4) | ATM+/+ (n=7) | ATM+/− (n=6) | |
| No. | 3 | 3 | 11 | 12 |
| BW, g | 28.75±0.79 | 27.32±0.88 | 25.49±1.72 | 26.15±0.85 |
| HW/BW | 5.20±0.25 | 5.40±0.28 | 7.47±1.01 | 8.52±1.28 |
| LW/BW | 4.95±0.13 | 4.82±0.09 | 6.38±0.62 | 7.62±0.83 |
| IVSd | 0.86±0.09 | 0.85±0.14 | 0.81±0.11 | 0.49±0.20 |
| IVSs | 1.52±0.08 | 1.45±0.06 | 1.15±0.19 | 0.59±0.27 |
| LVIDd | 3.44±0.02 | 3.41±0.16 | 4.98±0.84 | 5.85±1.67 |
| LVIDs | 1.91±0.05 | 1.96±0.28 | 4.16±1.11 | 5.39±1.95 |
| LVPWd | 0.85±0.08 | 0.78±0.02 | 0.58±0.20 | 0.55±0.31 |
| LVPWs | 1.40±0.11 | 1.28±0.08 | 0.83±0.35 | 0.73±0.48 |
| EF, % | 77.16±1.66 | 74.55±2.21 | 38.18±4.75 | 20.83±4.36 |
| FS, % | 44.82±1.26 | 42.58±3.35 | 19.34±3.91 | 9.89±2.01 |
| LV mass (corrected) | 81.26±0.07 | 74.47±2.25 | 103.01±18.74 | 94.16±31.13 |
Values are mean±SEM. ATM indicates ataxia telangiectasia mutated; BW, body weight; EF, ejection fraction; FS, fractional shortening; HW, heart weight; IVSd, interventricular septum in diastole; IVSs, interventricular septum in systole; LV, left ventricular; LVIDd, left ventricular internal diameter in diastole; LVIDs, left ventricular internal diameter in systole; LVPWd, left ventricular posterior wall in diastole; LVPWs, left ventricular posterior wall in systole; LW, lung weight.
P<0.05 vs the corresponding sham group.
P<0.05 vs the control myocardial infarction (MI) group.
Figure 4Ataxia telangiectasia mutated (ATM) haplodeficiency increased cardiac fibrosis post myocardial infarction (MI). A, Representative Masson's trichrome staining of cardiac sections in ATM +/+ and ATM +/− mice at day 28 after sham or MI surgery. B, Wall thickness of scar tissue and quantitative analysis of (C) infarct size at day 28 after MI in ATM +/+ and ATM +/− mice. D, Expansion index of left ventricle at 28 days after MI in ATM +/+ and ATM +/− mice. E, Quantification of fibrosis in infarcted and noninfarcted areas 28 days after MI in ATM +/+ and ATM +/− mice. F, Representative picrosirius red–stained sections of infarct, border, and remote areas 28 days after MI in ATM +/+ and ATM +/− mice. n=7 in the ATM +/+ MI group, n=6 in the ATM +/− group. *P<0.05 vs the ATM +/+ MI group. NS indicates not significant. Bar=50 μm.
Figure 5Ataxia telangiectasia mutated (ATM) haplodeficiency increases myofibroblast accumulation and decreases fibroblast senescence both in vivo and in vitro. A, Quantitative real‐time polymerase chain reaction (PCR) was performed to detect the mRNA level of α‐smooth muscle actin (α‐SMA), collagen I, and collagen III in the hearts of ATM +/+ and ATM +/− mice at the indicated time points post‐myocardial infarction (MI). n=4 in each group. *P<0.05, # P<0.01 vs the corresponding sham group; † P<0.05 vs the control MI group. B, Western blot analysis of α‐SMA levels in the hearts of ATM +/+ and ATM +/− mice at the indicated time points post MI. C, Representative collagen I–stained sections of infarct, border, and remote size 7 days after MI in ATM +/+ and ATM +/− mice. D, Western blot analysis of p21 levels in the hearts of ATM +/+ and ATM +/− mice at the indicated time points post MI. E, Representative images and statistical analysis of senescence‐associated β‐galactosidase (SA‐β‐gal) staining in cardiac sections from ATM +/+ and ATM +/− mice after MI. F, Representative images of costaining of p19 or p‐p53 with α‐SMA in ATM +/+ and ATM +/− mice after MI. G, Representative images and statistical analysis of SA‐β‐gal staining in isolated cardiac fibroblasts after hypoxia/oxygenation treatment and (H) cardiac fibroblasts from ATM +/+ and ATM +/− mice after MI surgery. n=4 in each group. *P<0.05 vs the corresponding ATM +/− group. Bar=50 μm.
Figure 6Ataxia telangiectasia mutated (ATM) haplodeficiency suppresses post–myocardial infarction (MI) angiogenesis. A, Immunohistochemical staining and bar graph showing CD31 expression and angiogenesis at day 28 in the hearts of ATM +/+ and ATM +/− mice post MI. B, Western blot analysis (C) showed CD31, vascular endothelial cadherin (VE‐cadherin), and vascular endothelial growth factor (VEGF) expressions in the hearts of ATM +/+ and ATM +/− mice at day 7 post MI. D, Quantitative real‐time polymerase chain reaction analysis showed the mRNA levels of chemokine (C‐X‐C motif) ligand (Cxcl) 1, Cxcl12, VEGF, and Cxcl8 in isolated cardiac fibroblasts (CFs) from ATM +/+ and ATM +/− mice after MI surgery. E, Western blot analysis of VEGF expression in cultured medium of isolated CFs from ATM +/+ and ATM +/− mice after MI surgery. F, Representative images and bar graph showing tube formation capacity of human umbilical vein endothelial cells on matrigel with stimulation of conditional culture medium from isolated CFs of ATM +/+ and ATM +/− mice after MI surgery. n=5 in each group. *P<0.05 vs corresponding ATM +/+ group. Bar=50 μm. # P<0.01. IL indicates interleukin; NS, not significant.